- Global Pharma News & Resources

Press Releases - 2020-11-30

Date Title Company
30-Nov-2020 PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia PTC Therapeutics, Inc.
30-Nov-2020 Nuritas Puts Muscle Health Peptides to the Test in Human Trials Nuritas
30-Nov-2020 Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis ABIVAX
30-Nov-2020 Pandemic to delay cancer advances by nearly 18 months, researchers fear The Institute of Cancer Research
30-Nov-2020 New guide helps unlock NHS for innovators to accelerate uptake of digital health technology BOEHRINGER INGELHEIM IN
30-Nov-2020 Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets Kaia Health and Chiesi Group
30-Nov-2020 Dupixent® (dupilumab) approved by European Commission as first and only biologic medicine for children aged 6 to 11 years with severe atopic dermatitis Sanofi
30-Nov-2020 Khondrion shares progress of sonlicromanol development programme at Mitochondrial Medicine 2020 virtual conference Khondrion
30-Nov-2020 VAL201 Clinical Trial Full Data Results ValiRx plc
30-Nov-2020 Forxiga approved in Japan for chronic heart failure AstraZeneca
30-Nov-2020 Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization Moderna
30-Nov-2020 Autolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine Autolus Therapeutics plc
30-Nov-2020 ViiV Healthcare and the Medicines Patent Pool expand access to dolutegravir-based regimens for people living with HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia with innovative new licensing agreement ViiV Healthcare
30-Nov-2020 M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion of the product business as core task of the integration of the Haemato Group into the M1 Kliniken AG - Group M1 Kliniken AG
30-Nov-2020 Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021 according to CPhI Report CPhI
30-Nov-2020 First results of the DiabetRisk study – Over 8% of patients identified with undiagnosed diabetes or pre-diabetes at dental practices Sunstar
30-Nov-2020 New Publication from I-SPY 2 Trial Highlights Signatera's Ability to Predict Treatment Outcomes in Neoadjuvant Breast Cancer Patients Natera, Inc.
30-Nov-2020 HAEMATO AG: Expansion of the board of directors: Strengthening the strategic and operative implementa-tion of the product business in the Haemato Group HAEMATO AG
30-Nov-2020 Elevar Therapeutics Appoints Gus Aromin as Vice President of Regulatory Affairs Elevar Therapeutics
30-Nov-2020 LGC's high-throughput PCR testing system for SARS-CoV-2 detection, submitted for Emergency Use Authorisation, capable of processing up to 35,000 tests per day LGC